Clinical Trial Update: Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer

View source ↗

Summary

A completed Sanofi-sponsored trial evaluating bisphosphonate therapy for osteopenia/osteoporosis in men with prostate cancer, emphasizing treatment awareness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Prostate Cancer

Drugs mentioned

• Bisphosphonate

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Prostate Cancer | Status: COMPLETED